A combined diabetes renal clinic improves risk factor management and progression of renal disease in a district general hospital

Journal of Evaluation in Clinical Practice

Volumn 15, Issue 5, 2009, Pages 832-835

  McKay, Gerard A ^a,b   Patel, Manish ^c   Shilliday, Ilona R ^d  

^a MONKLANDS HOSPITAL   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^d NONE

Author keywords

Audit; Clinic; Combined; Diabetes; Nephropathy; Renal

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HEALTH CENTER; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; PATIENT CARE; PRIORITY JOURNAL; PUBLIC HOSPITAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; WEIGHT CHANGE;

DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; DISEASE PROGRESSION; FEMALE; HOSPITALS, DISTRICT; HUMANS; KIDNEY FAILURE; MALE; MEDICAL AUDIT; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; RISK FACTORS; RISK REDUCTION BEHAVIOR; SCOTLAND;

EID: 70349484681     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2008.01097.x     Document Type: Article

References (18)

1. US Renal Data System (2003) USDRS Annual Data Report: Atlas of End Stage Renal Disease in the United States. National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, 2003. Available from http://www.usrds.org/adr-2003.htm (last accessed July 2008).
2. Hasslacher, C., Stech, W., Wahl, P. Ritz, E. (1985) Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia, 28 (1 6 11. (Pubitemid 15155987)
3. Fried, L. F., Orchard, T. J. Kasiske, B. L. (2001) Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney International, 59 (1 260 269.
4. Parving, H. H. Hommel, E. (1988) High blood pressure is a major factor in progression of diabetic nephropathy. Journal of Diabetic Complications, 2 (2 92 95.
5. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352 (9131 837 853.
6. Parving, H. H., Lehnert, H., Brochner-Mortensen, J., Gomis, R., Andersen, S. Arner, P. (2001) The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. New England Journal of Medicine, 345 (12 870 878. (Pubitemid 34940826)
7. Scottish Intercollegiate Guideline Network (SIGN) (2001) Management of Diabetes: SIGN Guideline 55. Available at : http://www.sign.ac.uk/guidelines/ fulltext/55/index.html (last accessed July 2008).
8. CG66 - Diabetes type 2 update (May 2008). National Clinical Guideline for the management in primary and secondary care. Available at : http://www.nice.org.uk/nicemedia/pdf/CG66diabetesfullguideline.pdf (last accessed July 2008).
9. Liew, B., Perry, C., Boulton-Jones, J., Simpson, K. Paterson, K. (1997) Diabetic nephropathy: an observational study on patients attending a joint diabetes renal clinic. Quarterly Journal of Medicine, 90 (5 353 358.
10. Joss, N., Paterson, K. R., Deighan, C. J., Simpson, K. Boulton-Jones, J. M. (2002) Diabetic nephropathy: how effective is treatment in clinical practice? Quarterly Journal of Medicine, 95 (1 41 49.
11. Jayapaul, M. K., Messersmith, R., Bennett-Jones, D. N., Mead, P. A. Large, D. M. (2006) The joint diabetic-renal clinic in clinical practice: 10 years of data from a District General Hospital. Quarterly Journal of Medicine, 99 (3 153 160.
12. Molitch, M. E., DeFronzo, R. A., Franz, M. J., Keane, W. F., Mogensen, C. E., Parving, H. H., Steffes, M. W., American Diabetes Association (2004) Nephropathy in diabetes. Diabetes Care, 27 (Suppl. 1 s79 s83.
13. Feest, T. G., Dunn, E. J. Burton, C. J. (1999) Can intensive treatment alter the progress of established diabetic nephropathy to end-stage renal failure? Quarterly Journal of Medicine, 92 (5 275 282.
14. UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). British Medical Journal, 317 (7160 703 713.
15. Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N. Roth, D. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Annals of Internal Medicine, 130 (6 461 470.
16. Rolin, H. A., Hall, P. M. Wei, R. (1984) Inaccuracy of estimated creatinine clearance for prediction of iothalamate glomerular filtration rate. American Journal of Kidney Diseases, 4 (1 48 54.
17. Foley, R. N., Parfrey, P. S. Sarnak, M. J. (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. American Journal of Kidney Diseases, 32 (5 Suppl. 3 S112 S119.
18. Scottish Diabetes Framework (2002). Available from http://www.scotland. gov.uk/publications/2002/04/14452/1980 (last accessed July 2008).